Search Results 1101-1110 of 17721 for corticosteroid

1. Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/​Round Cell Liposarcoma - Mayo Clinic

   study), Corticosteroids or any other immunosuppressive therapy, Investigational treatment or interventional clinical trial, Allogeneic hematopoietic stem ...

2. A Study to Assess the Effectiveness and Safety of Ublituximab in combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

   Corticosteroid use within 1 week prior to first dose of study drug are ... corticosteroids. Patients requiring systemic steroids for leukemia control ...

3. A Study of the Safety and Effectiveness of HBI-8000 with Nivolumab to Treat Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer - Mayo Clinic

   Subjects with a condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications ...

4. Butalbital, acetaminophen, and caffeine (oral route) - Mayo Clinic

   However, people who have continuing pain should not let the fear of dependence keep them from using narcotics to relieve their pain. Physical dependence may ...

5. A Study to Evaluate the Safety and Feasibility of Platelet-rich Plasma to Treat Facetogenic Low Back Pain - Mayo Clinic

   to the first medial branch nerve block. Exclusion Criteria: - Prior facet related procedure (intraarticular corticosteroid injection, radiofrequency

6. Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer - Mayo Clinic

   Notes: Patients previously treated or untreated for this condition who are asymptomatic in the absence of corticosteroid and anti-epileptic therapy are allowed.

7. A Study to Evaluate the Safety, Tolerability, and Determine the Optimal Dose for the Expansion Cohorts of VSV-IFNβ-NIS in Combination with Pembrolizumab in Patients with Refractory Solid Tumors - Mayo Clinic

   exception of hypothyroidism and type 1 diabetes that are controlled with treatment. - Immunodeficiency or immunosuppression, including systemic corticosteroids ...

8. Probenecid (oral route) - Mayo Clinic

   Probenecid is used in the treatment of chronic gout or gouty arthritis. These conditions are caused by too much uric acid in the blood. The medicine works by ...

9. Physical Medicine and Rehabilitation - Overview - Mayo Clinic

   PM&R physicians diagnose and treat a variety of medical conditions affecting the brain, spinal cord, nerves and the musculoskeletal system. They provide ...

10. Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction - Mayo Clinic

    ... corticosteroids; subjects on a stable dose of corticosteroids > 1 month or who have been off corticosteroids for at least 2 weeks can be enrolled with ...